Notice of Intent to Award Sole Source - Extension of Mammography Quality Standards Act (MQSA) Certification and Hotline Inquiries Contract
Closed Special Notice Posted
- Solicitation number
- FDA-NOI-133411
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541511 Custom Computer Programming Services
- Place of performance
- Fulton, Maryland 20759, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Food and Drug Administration (FDA) Office of Acquisition and Grant Services published a Notice of Intent to Award a sole source contract extension on March 30, 2026. The notice announces the FDA's intention to extend its existing labor hour contract with Impyrian LLC for a six-month period to continue supporting the Mammography Quality Standards Act (MQSA) program. This procurement is classified under NAICS Code 541511 (Custom Computer Programming Services) and is being executed under the authority of FAR Part 6, which permits sole source awards when only one responsible source is available. The contract extension follows FAR Part 52.217-8 acquisition procedures and is not being set aside for any specific category of contractor.
The primary objectives of this contract extension include operating and maintaining the federal certificate issuance system for mammography facilities, maintaining the MQSA hotline system to respond to inquiries from facilities, consumers, inspectors, and stakeholders, and operating the database system that scans mammography certification letters. Interested firms must submit documentation demonstrating their capability and interest in performing these requirements to Thomas Lawson at Thomas.lawson@fda.hhs.gov no later than 5:00 pm EDT on April 3, 2026. While this notice is not a competitive request for quotes, other firms may submit proposals challenging the sole source justification if they can demonstrate their ability to meet the requirements. The contract encompasses technical and administrative support functions related to MQSA program matters, including responding to inquiries via email, telephone, facsimile, and written communications from multiple stakeholder groups within the mammography industry.
Notice text
The Food and Drug Administration (FDA) intends to award a Sole Source labor hour 6-month contract extension to Impyrian LLC, 8115 Maple Lawn BLVD, Suite 260, Fulton, Maryland 20759-2681 for the Mammography Quality Standards Act Program, in accordance with the authority under FAR Part 6 (i.e. 6.103-1, Only One Responsible Source). This procurement is being extended through the acquisition procedures in accordance with FAR Part 52.217-8. The NAICS Code for this action is 541511 – Custom Computer Programming Services.
The primary objective of this requirement is to 1. operate and maintain the current system for the issuance of federal certificates to mammography facilities under the MQSA. 2. Operate and maintain the current MQSA hotline certification inquiries system, including real-time responses, maintaining records of written, telephone, email, and fax inquiries from facilities, consumers, MSQA inspectors and mammography stakeholders. 3. Operate and maintain the current database system to scan all mammography certification letters mailed to facilities.
The scope of the activities supported by this contract requires the Contractor to perform in support of the Mammography Quality Standards Act (MQSA) Facility Certificate Issuance and Hotline Inquiries program functions. DMQS provides technical and administrative information to mammography manufactures (post-marked), mammography facilities, consumers, MQSA inspectors, FDA-approved accreditation body stakeholders, FDA-approved certifying agencies and FDA CDRH program offices through responses to inquires via email messages, phone calls, faxes and written communications pertaining to the MQSA program related matters.
Responses:
Responses to this notice should be sent to Thomas Lawson at Thomas.lawson@fda.hhs.gov NLT 5:00 pm (EDT), April 3, 2026.
This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of intent to award a sole source | Naval Supply Systems Command | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity